BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Bakulin I, Pasechnikov V, Varlamicheva A, Sannikova I. NS3 protease inhibitors for treatment of chronic hepatitis C: Efficacy and safety. World J Hepatol 2014; 6(5): 326-339 [PMID: 24868326 DOI: 10.4254/wjh.v6.i5.326]
URL: https://www.wjgnet.com/1948-5182/full/v6/i5/326.htm
Number Citing Articles
1
Hui-Chun Li, Shih-Yen Lo. Hepatitis C virus: Virology, diagnosis and treatmentWorld Journal of Hepatology 2015; 7(10): 1377-1389 doi: 10.4254/wjh.v7.i10.1377
2
Nancy W. Withers. Handbook of Consultation-Liaison Psychiatry2015; : 445 doi: 10.1007/978-3-319-11005-9_30
3
Elizabeth Yihui Ng, Ying Ru Loh, Yan Li, Qingxin Li, CongBao Kang. Expression, purification of Zika virus membrane protein-NS2B in detergent micelles for NMR studiesProtein Expression and Purification 2019; 154: 1 doi: 10.1016/j.pep.2018.09.013
4
Keiko I. Greenberg, Mark A. Perazella, Mohamed G. Atta. HIV and HCV Medications in End-Stage Renal DiseaseSeminars in Dialysis 2015; 28(4): 397 doi: 10.1111/sdi.12367
5
V. L. Korobka, E. S. Pak, V. D. Pasechnikov, M. Yu. Kostrykin. Compensation of HCV-associated decompensated cirrhosis treated with modern direct-acting antiviral agentsDokazatel'naya gastroenterologiya 2019; 8(4-5): 11 doi: 10.17116/dokgastro2019804-05111